KR20070054208A - 아자비사이클로헥산의 신규한 다형체 - Google Patents

아자비사이클로헥산의 신규한 다형체 Download PDF

Info

Publication number
KR20070054208A
KR20070054208A KR1020077006293A KR20077006293A KR20070054208A KR 20070054208 A KR20070054208 A KR 20070054208A KR 1020077006293 A KR1020077006293 A KR 1020077006293A KR 20077006293 A KR20077006293 A KR 20077006293A KR 20070054208 A KR20070054208 A KR 20070054208A
Authority
KR
South Korea
Prior art keywords
polymorph
acid addition
azabicyclo
polymorph form
dichlorophenyl
Prior art date
Application number
KR1020077006293A
Other languages
English (en)
Korean (ko)
Inventor
에릭 제이. 하겐
케빈 할로란
Original Assignee
도브 파마슈티칼 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 도브 파마슈티칼 인코포레이티드 filed Critical 도브 파마슈티칼 인코포레이티드
Publication of KR20070054208A publication Critical patent/KR20070054208A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
KR1020077006293A 2004-08-18 2005-08-17 아자비사이클로헥산의 신규한 다형체 KR20070054208A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92074804A 2004-08-18 2004-08-18
US10/920,748 2004-08-18

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020127030289A Division KR20130004370A (ko) 2004-08-18 2005-08-17 아자비사이클로헥산의 신규한 다형체

Publications (1)

Publication Number Publication Date
KR20070054208A true KR20070054208A (ko) 2007-05-28

Family

ID=35968183

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020137024105A KR20130108489A (ko) 2004-08-18 2005-08-17 아자비사이클로헥산의 신규한 다형체
KR1020077006293A KR20070054208A (ko) 2004-08-18 2005-08-17 아자비사이클로헥산의 신규한 다형체
KR1020127030289A KR20130004370A (ko) 2004-08-18 2005-08-17 아자비사이클로헥산의 신규한 다형체

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020137024105A KR20130108489A (ko) 2004-08-18 2005-08-17 아자비사이클로헥산의 신규한 다형체

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020127030289A KR20130004370A (ko) 2004-08-18 2005-08-17 아자비사이클로헥산의 신규한 다형체

Country Status (14)

Country Link
EP (1) EP1786417A4 (de)
JP (1) JP2008510715A (de)
KR (3) KR20130108489A (de)
CN (1) CN101052393A (de)
AU (1) AU2005277351A1 (de)
BR (1) BRPI0515193A (de)
CA (1) CA2619817A1 (de)
IL (1) IL181185A (de)
MX (1) MX2007001827A (de)
NO (1) NO20071372L (de)
NZ (1) NZ589033A (de)
RU (1) RU2007109817A (de)
WO (1) WO2006023659A2 (de)
ZA (1) ZA200701570B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
EP2719384B1 (de) 2005-07-27 2018-08-08 Otsuka America Pharmaceutical, Inc. Neue 1-naphthyl-3-azabicyclo [3.1.0] hexan: Herstellung und Verwendung zur Behandlung neuropsychiatrischer Erkrankungen
US20080045725A1 (en) * 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
US8138377B2 (en) 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
AU2011336318A1 (en) * 2010-12-03 2013-07-04 Euthymics Bioscience, Inc. Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
EP2994129A4 (de) * 2013-05-07 2017-01-25 Euthymic Bioscience, Inc. Verwendung von (+)-1-(3,4-dichlorphenyl)-3-azabicyclo-[3.1.0]-hexan zur behandlung von sucht- und alkoholbedingten erkrankungen
KR101567003B1 (ko) 2013-12-27 2015-11-06 경희대학교 산학협력단 골편 고정장치 및 골편 절단을 위한 드릴 어셈블리
SI3597189T1 (sl) 2015-06-17 2022-08-31 Otsuka America Pharmaceutical, Inc. Kristalinične spojine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435419A (en) * 1981-07-01 1984-03-06 American Cyanamid Company Method of treating depression using azabicyclohexanes
US6372919B1 (en) * 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent

Also Published As

Publication number Publication date
NO20071372L (no) 2007-05-18
CA2619817A1 (en) 2006-03-02
EP1786417A4 (de) 2009-05-20
IL181185A0 (en) 2007-07-04
KR20130108489A (ko) 2013-10-02
MX2007001827A (es) 2007-04-23
CN101052393A (zh) 2007-10-10
RU2007109817A (ru) 2008-09-27
AU2005277351A1 (en) 2006-03-02
WO2006023659A3 (en) 2006-12-07
KR20130004370A (ko) 2013-01-09
JP2008510715A (ja) 2008-04-10
EP1786417A2 (de) 2007-05-23
NZ589033A (en) 2012-06-29
ZA200701570B (en) 2008-08-27
BRPI0515193A (pt) 2008-07-08
WO2006023659A2 (en) 2006-03-02
IL181185A (en) 2012-10-31

Similar Documents

Publication Publication Date Title
KR20070054208A (ko) 아자비사이클로헥산의 신규한 다형체
US9770436B2 (en) Polymorphs of azabicyclohexane
AU2008272685B2 (en) Process for introduction of hydroxyethoxy side chain in bosentan
JP2014510139A (ja) 固体形態のｈｉｖ阻害剤
CN116615424A (zh) 经取代的吡唑并嘧啶的固态形式和其用途
EP2455368B1 (de) 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluormethoxy)phenyl]-3-pyridincarboxamid-benzen- sulfonat, kristalle davon, polymorphe daraus und herstellungsverfahren dafür
US20090176787A1 (en) Crystalline Forms of lamotrigine
US20080262029A1 (en) Acid and Base Salt Forms of Gaboxadol
EP2601175A1 (de) Neuartige kristallinverbindung mit saxagliptin und phosphorsäue
KR20170033684A (ko) 리나글립틴 결정형 및 이의 제조방법
EP2740458B1 (de) Verpackung, entahltend Formen des Natriumsalzes von 4-tert-butyl-N-[4-chlor-2-(1-oxy-pyridin-4-carbonyl)-phenyl]-benzensulfonamid
KR101336143B1 (ko) 클로피도그렐의 공결정
AU2012203400B2 (en) Novel polymorphs of azabicyclohexane
US8258155B2 (en) Quinine sulfate/bisulfate solid complex; methods of making; and methods of use thereof
US11905231B1 (en) Solid forms, salts and polymorphs of anti-fibrotic compounds
WO2023225773A1 (en) Solid forms of mesembrine and therapeutic uses thereof
KR101423630B1 (ko) 비칼루타미드와 니코틴아미드의 공결정
JP2024508375A (ja) ラトレピルジン二塩酸塩の多形体
EP1713769B1 (de) Amorphes tamsulosin-hydrochlorid
AU7595998A (en) Sulfate salt of an HIV protease inhibitor having an improved oral absorption and bioavailability
KR20130033243A (ko) 아데포비어 디피복실의 공결정
CZ2002432A3 (cs) Volná amlodinová báze

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
A107 Divisional application of patent
E601 Decision to refuse application